Page 1 | Search Results | Blood | American Society of Hematology

1-13 of 13

Sort by

Sort Order Select

Journal Articles

Deferasirox Compared With Deferoxamine For The Removal Of Cardiac Iron In Patients With β-Thalassemia Major: 2-Year Data From The Cordelia Extension

Dudley J Pennell, MD, John B Porter, MD, Antonio Piga, MD, Yongrong Lai, MD, Amal El-Beshlawy, MD, Khawla Belhoul, MD, Mohsen Elalfy, MD, Akif Yesilipek, MD, Yurdanur Kilinç, MD, Antje Wegener, MD, Dany Habr, MD, Junwu Shen, PhD, Yesim Aydinok, MD

Blood (2013) 122 (21): 1018.

https://doi.org/10.1182/blood.V122.21.1018.1018

Published: 2013

Journal Articles

A Multicenter, Randomized, Open-Label Trial Evaluating Deferasirox Compared with Deferoxamine for the Removal of Cardiac Iron in Patients with β-Thalassemia Major and Iron Overload (CORDELIA).

Dudley J Pennell, MD, John B Porter, MD, Antonio Piga, MD, Yongrong Lai, MD, Amal El-Beshlawy, MD, Khawla Beloul, MD, Mohsen Elalfy, MD, Akif Yesilipek, MD, Yurdanur Kilinç, MD, Tomasz Lawniczek, MD, Dany Habr, MD, Marianne Weisskopf, PhD, Yiyun Zhang, PhD, Yesim Aydinok, MD

Blood (2012) 120 (21): 2124.

https://doi.org/10.1182/blood.V120.21.2124.2124

Published: 2012

Journal Articles

A Decade Follow-up of a Thalassemia Major (TM) Cohort Monitored by Cardiac Magnetic Resonance Imaging (CMR): Significant Reduction In Patients with Cardiac Iron and In Total Mortality

Alison S Thomas, MBBS, Maciej Garbowski, MBBS, Ai Leen Ang, MBBS, Farrukh T Shah, MBBS, MD, J. Malcolm Walker, MBBS, James C Moon, MBBCh, MD, Dudley J Pennell, MD, John B Porter, MD

Blood (2010) 116 (21): 1011.

https://doi.org/10.1182/blood.V116.21.1011.1011

Published: 2010

Journal Articles

Improved Endothelial Function with Combined Chelation Therapy in Thalassaemia Major.

Mark A. Tanner, MRCP, Renzo Galanello, MD, Carlo Dessi, MD, Annalisa Agus, MD, Gillian C. Smith, MSc, Mark A. Westwood, MD, Ravi Assomull, MRCP, Sunil V. Nair, MRCP, J. Malcolm Walker, MD, Dudley J. Pennell, MD

Blood (2006) 108 (11): 1770.

https://doi.org/10.1182/blood.V108.11.1770.1770

Published: 2006

Journal Articles

Validation of T2* Technique in Ex-Vivo Myocardial Tissue.

Paul Kirk, MBBS, BSc, MRCP, David N. Firmin, PhD, Barry Sampson, PhD, John B. Porter, MD, Malcolm J. Walker, MD, Dudley J. Pennell, MD, FRCP, FESC, FACC

Blood (2005) 106 (11): 3718.

https://doi.org/10.1182/blood.V106.11.3718.3718

Published: 2005

Journal Articles

Myocardial T2* in Patients with Cardiac Failure Secondary to Iron Overload.

Mark A. Tanner, MBBS, John B. Porter, MD, Mark A. Westwood, MD, Sunil V. Nair, MBBS, Lisa J. Anderson, MD, J. M. Walker, MD, Dudley J. Pennell, MD

Blood (2005) 106 (11): 3838.

https://doi.org/10.1182/blood.V106.11.3838.3838

Published: 2005

Journal Articles

Improved Myocardial T2* in Transfusion Dependent Anemias Receiving ICL670 (Deferasirox).

John B. Porter, MD, Mark A. Tanner, MRCP, Dudley J. Pennell, MD, Perla Eleftheriou, MD

Blood (2005) 106 (11): 3600.

https://doi.org/10.1182/blood.V106.11.3600.3600

Published: 2005

Journal Articles

Normalized Left Ventricular Volumes and Function in Thalassemia Major Patients with Normal Myocardial Iron.

Mark A. Westwood, MD, Lisa J. Anderson, MD, Alicia M. Maceira, MD, Emma Prescott, BSc, John B. Porter, PhD, Beatrix Wonke, MD, Malcolm J. Walker, MD, Dudley J. Pennell, MD

Blood (2005) 106 (11): 2707.

https://doi.org/10.1182/blood.V106.11.2707.2707

Published: 2005

Journal Articles

A Randomized, Placebo Controlled, Double Blind Trial of the Effect of Combined Therapy with Deferoxamine and Deferiprone on Myocardial Iron in Thalassaemia Major Using Cardiovascular Magnetic Resonance.

Mark A. Tanner, MD, Renzo Galanello, MD, Carlo Dessi, MD, Mark A. Westwood, MD, Gillian C. Smith, MSc, Mohammed Khan, MSc, Sunil V. Nair, MD, J. M. Walker, MD, Dudley J. Pennell, MD

Blood (2005) 106 (11): 3655.

https://doi.org/10.1182/blood.V106.11.3655.3655

Published: 2005

Journal Articles

Inter-Site Validation of a Single Breath Hold T2* MR Technique for Heart and Liver Iron Measurement.

Paul Kirk, MBBS, BSc, MRCP, Lisa J. Anderson, MD, Mark A. Tanner, MBBS, Renzo Galanello, MD, Gildo Matta, MD, Ru S. Tan, MD, Ivg Ng, MD, Angie Lai, MD, Kevin Chen, MD, David N. Firmin, MD, Dudley J. Pennell, MD, FRCP, FESC, FACC

Blood (2005) 106 (11): 3830.

https://doi.org/10.1182/blood.V106.11.3830.3830

Published: 2005

Journal Articles

The Effect of Combined Chelation Therapy in the Treatment of Severe Myocardial Iron Loading in Beta Thalassaemia Major.

Mark A. Tanner, MBBS, Renzo Galanello, MD, Carlo Dessi, MD, Mark A. Westwood, MD, Dudley J. Pennell, MD

Blood (2005) 106 (11): 3836.

https://doi.org/10.1182/blood.V106.11.3836.3836

Published: 2005

Journal Articles

Calibration of Myocardial T2* Values in Post-Mortem Hearts.

Dudley J. Pennell, MD, Lisa J. Anderson, MD, Kirk Paul, MBBS, Gian Luca Forni, MD, Gareth Ellis, MD, J. M. Walker, MD, John B. Porter, MD

Blood (2005) 106 (11): 3837.

https://doi.org/10.1182/blood.V106.11.3837.3837

Published: 2005

Journal Articles

Myocardial T2* Is Not Affected by the Structural Effects of Myocardial Fibrosis, Ageing or Impaired Left Ventricular Function.

Paul Kirk, MBBS, BSc, MRCP, Dudley J. Pennell, MD, FRCP, FESC, FACC

Blood (2005) 106 (11): 1675.

https://doi.org/10.1182/blood.V106.11.1675.1675

Published: 2005

NARROW

Deferasirox Compared With Deferoxamine For The Removal Of Cardiac Iron In Patients With β-Thalassemia Major: 2-Year Data From The Cordelia Extension

A Multicenter, Randomized, Open-Label Trial Evaluating Deferasirox Compared with Deferoxamine for the Removal of Cardiac Iron in Patients with β-Thalassemia Major and Iron Overload (CORDELIA).

A Decade Follow-up of a Thalassemia Major (TM) Cohort Monitored by Cardiac Magnetic Resonance Imaging (CMR): Significant Reduction In Patients with Cardiac Iron and In Total Mortality

Improved Endothelial Function with Combined Chelation Therapy in Thalassaemia Major.

Validation of T2* Technique in Ex-Vivo Myocardial Tissue.

Myocardial T2* in Patients with Cardiac Failure Secondary to Iron Overload.

Improved Myocardial T2* in Transfusion Dependent Anemias Receiving ICL670 (Deferasirox).

Normalized Left Ventricular Volumes and Function in Thalassemia Major Patients with Normal Myocardial Iron.

A Randomized, Placebo Controlled, Double Blind Trial of the Effect of Combined Therapy with Deferoxamine and Deferiprone on Myocardial Iron in Thalassaemia Major Using Cardiovascular Magnetic Resonance.

Inter-Site Validation of a Single Breath Hold T2* MR Technique for Heart and Liver Iron Measurement.

The Effect of Combined Chelation Therapy in the Treatment of Severe Myocardial Iron Loading in Beta Thalassaemia Major.

Calibration of Myocardial T2* Values in Post-Mortem Hearts.

Myocardial T2* Is Not Affected by the Structural Effects of Myocardial Fibrosis, Ageing or Impaired Left Ventricular Function.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only